Source index · 71 unique records
Trace every conclusion to the record.
Browse the labels, regulatory pages, trials, human pharmacology, reviews, and preclinical studies used across reviewed briefs.
71 unique records
Shared records are listed once with every connected brief.OZEMPIC (semaglutide) prescribing information, revised 05/2026
Used bySemaglutide
RYBELSUS (semaglutide) prescribing information, revised 10/2025
Used bySemaglutide
WEGOVY (semaglutide) prescribing information, revised 03/2026
Used bySemaglutide
FDA’s concerns with unapproved GLP-1 drugs used for weight loss
Drug approvals and databases
Insulin: patient and product overview
Used byInsulin
HUMALOG (insulin lispro) prescribing information
Used byInsulin
The effect of intensive treatment of diabetes on long-term complications in insulin-dependent diabetes mellitus
Used byInsulin
Hypoglycemia in the Diabetes Control and Complications Trial
Used byInsulin
FDA approves the first rapid-acting insulin biosimilar product for diabetes
Used byInsulin
2026 prohibited list
MOUNJARO (tirzepatide) prescribing information
Used byTirzepatide
ZEPBOUND (tirzepatide) prescribing information
Used byTirzepatide
Tirzepatide once weekly for the treatment of obesity
Used byTirzepatide
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
Used byTirzepatide
July 2026 PCAC briefing on BPC-157-related bulk drug substances
Used byBPC-157
Certain bulk drug substances for use in compounding that may present significant safety risks
BPC-157 as an investigational peptide therapeutic: translational development barriers
Used byBPC-157
Safety of intravenous infusion of BPC157 in humans: a pilot study
Used byBPC-157
Promoting effect of BPC 157 on tendon healing: tendon outgrowth, cell survival, and migration
Used byBPC-157
BPC 157 for acute hamstring muscle strain repair
Used byBPC-157
Prolonged GH and IGF-1 stimulation by CJC-1295 in healthy adults
Used byCJC-1295
Pulsatile GH secretion during continuous stimulation by CJC-1295
Used byCJC-1295
CJC-1295 pharmacy compounding advisory review
Used byCJC-1295
Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers
Used byIpamorelin
Randomized proof-of-concept study of ipamorelin for postoperative ileus
Used byIpamorelin
VICTOZA (liraglutide) prescribing information
Used byLiraglutide
SAXENDA (liraglutide) prescribing information
Used byLiraglutide
Liraglutide and cardiovascular outcomes in type 2 diabetes
Used byLiraglutide
LY3437943 in people with type 2 diabetes: a phase 1b randomized trial
Used byRetatrutide
Retatrutide for people with type 2 diabetes: a phase 2 randomized trial
Used byRetatrutide
Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial
Used byRetatrutide
Retatrutide for metabolic dysfunction-associated steatotic liver disease
Used byRetatrutide
TRIUMPH-1 phase 3 study record
Used byRetatrutide
TRIUMPH-2 phase 3 study record
Used byRetatrutide
TRIUMPH-3 phase 3 study record
Used byRetatrutide
TRIUMPH-1 topline results
Used byRetatrutide
TRIUMPH-2 and TRIUMPH-3 topline results
Used byRetatrutide
What to know about retatrutide
Used byRetatrutide
FDA concerns with unapproved GLP-1 drugs used for weight loss
Used byRetatrutide
EGRIFTA SV (tesamorelin) prescribing information
Used byTesamorelin
EGRIFTA WR (tesamorelin) prescribing information
Used byTesamorelin
Tesamorelin in HIV-associated abdominal fat accumulation
Used byTesamorelin
Geref (sermorelin acetate) approval package
Used bySermorelin
FDA determination that Geref was not withdrawn for safety or effectiveness
Used bySermorelin
Sermorelin in diagnosis and treatment of pediatric growth hormone deficiency
Used bySermorelin
FDA briefing document for TB-500-related bulk drug substances
Used byTB-500
TB-500 substance record
Used byTB-500
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
Used byGHK-Cu
503A bulk drug substances under evaluation
Used byGHK-Cu
FDA briefing document for MOTS-c-related bulk drug substances
Used byMOTS-c
MOTS-c substance record
Used byMOTS-c
FDA briefing document for AOD-9604-related bulk drug substances
Used byAOD-9604
Sterile compounded AOD-9604 recall for lack of sterility assurance
Used byAOD-9604
FDA briefing document for epitalon-related bulk drug substances
Used byEpitalon
Epitalon and telomere length in human cell lines
Used byEpitalon
July 2026 Pharmacy Compounding Advisory Committee meeting
Used byEpitalon
VYLEESI (bremelanotide) prescribing information
Used byBremelanotide
Bremelanotide for HSDD: two randomized phase 3 trials
Used byBremelanotide
Vyleesi multidisciplinary review
Used byBremelanotide
SCENESSE (afamelanotide) prescribing information
Used byAfamelanotide
Afamelanotide for erythropoietic protoporphyria
Used byAfamelanotide
Afamelanotide orphan drug designation and approval
Used byAfamelanotide
FORTEO (teriparatide) prescribing information
Used byTeriparatide
Parathyroid hormone for postmenopausal osteoporosis
Used byTeriparatide
Teriparatide and femoral-neck fracture healing
Used byTeriparatide
TYMLOS (abaloparatide) prescribing information
Used byAbaloparatide
Abaloparatide vs placebo on new vertebral fractures: ACTIVE
Used byAbaloparatide
GATTEX (teduglutide) prescribing information
Used byTeduglutide
Teduglutide reduces parenteral support in short bowel syndrome
Used byTeduglutide
Teduglutide orphan drug designation and approval
Used byTeduglutide
A transparent trail
One shared source can inform more than one brief.
The index deduplicates identical URLs, then shows every brief that uses the record. A source appearing here means we reviewed and cited it, not that it supports every claim about that peptide.